Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by Nathalie Bonnefoy
Group name EquipeNB
Item Type Journal Article
Title [Radiotherapy of bladder cancer]
Creator Riou et al.
Author O. Riou
Author B. Chauvet
Author J.-L. Lagrange
Author P. Martin
Author C. Llacer Moscardo
Author M. Charissoux
Author O. Lauche
Author P. Fenoglietto
Author D. Azria
Abstract Surgery (radical cystectomy) is the standard treatment of muscle-invasive bladder cancer. Radiochemotherapy has risen as an alternative treatment option to surgery as part as organ-sparing combined modality treatment or for patients unfit for surgery. Radiochemotherapy achieves 5-year bladder intact survival of 40 to 65% and 5-year overall survival of 40 to 50% with excellent quality of life. This article introduces the French recommendations for radiotherapy of bladder cancer: indications, exams, technique, dosimetry, delivery and image guidance.
Publication Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique
Volume 20 Suppl
Pages S196-199
Date Sep 2016
Journal Abbr Cancer Radiother
Language fre
DOI 10.1016/j.canrad.2016.07.010
ISSN 1769-6658
Library Catalog PubMed
Extra PMID: 27521030
Tags Bladder cancer, Cancer de vessie, Carcinoma, Transitional Cell, Combined Modality Therapy, Cystectomy, Dose Fractionation, Radiation, first-last-corresponding, Humans, Lymphatic Irradiation, Lymphatic Metastasis, Organs at Risk, Radiation Injuries, Radiothérapie, Radiotherapy, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Adjuvant, Radiotherapy, Image-Guided, Recommandations, Recommendations, review, Urinary Bladder Neoplasms
Date Added 2019/05/28 - 21:43:17
Date Modified 2019/05/28 - 21:43:35
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés